Artelo Biosciences(ARTL)
$2.07-0.03 (-1.43%)
ARTL
Artelo Biosciences financials statements
$2.07
At close:-0.03 (-1.43%)
Want to see ARTL full AI Analyst Report?
Artelo Biosciences (ARTL) Income Statement
591 Followers
Artelo Biosciences Income Statement
Last quarter (Q3 2026), Artelo Biosciences's total revenue was $0.00. In Q3, Artelo Biosciences's net income was $-1.77M. See Artelo Biosciences’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Mar 23 | Aug 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 11.40M | $ 10.11M | $ 9.93M | $ 10.29M | $ 7.44M | |
| Depreciation and Amortization | $ 146.00K | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| $ -12.54M | $ -9.83M | $ -9.29M | $ -10.08M | $ -7.44M | |
| $ -11.40M | $ -10.11M | $ -9.93M | $ -10.29M | $ -7.44M | |
| $ -1.48M | $ 282.00K | $ 641.00K | $ 204.00K | $ 4.00K | |
| $ -12.88M | $ -9.83M | $ -9.29M | $ -10.08M | $ -7.44M | |
| $ -12.88M | $ -9.83M | $ -9.29M | $ -10.08M | $ -7.44M | |
| Per Share Metrics | |||||
| Basic EPS | $ -49.23 | $ -9.15 | $ -9.42 | $ -10.47 | $ -17.91 |
| Diluted EPS | $ -49.23 | $ -9.15 | $ -9.42 | $ -10.47 | $ -17.91 |
| Weighted Average Shares Outstanding | 261.83K | 1.07M | 986.67K | 157.33K | 69.17K |
| Weighted Average Shares Outstanding (Diluted) | 261.83K | 1.07M | 986.67K | 157.39K | 69.17K |
Currency in USD
